DermBiont, Inc.
Biotechnology Research
451 D St
20 employees
ARQT
- Employees
- 20
- Contacts
- 2
- Emails
- 2
DermBiont, Inc. Overview
- Headquarters
- 451 D St
- Website
- dermbiont.com
- Industry
- Biotechnology Research
- Employees
- 20
- Founded
- 2017
- Stock Symbol
- ARQT
- Funding
- 35.2M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About DermBiont, Inc.
DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and biotherapeutics that repair an imbalance of the microbiome. The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 & DBI-002 for the treatment of atopic dermatitis, tinea pedis, and onychomycosis. For more information, please visit www.dermbiont.com.
DermBiont, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
DermBiont, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Daniel Geffken | Founder and Managing Director | Cambridge, Massachusetts, United States |
View
|
| Nichola Eliovits | Boston, Massachusetts, United States |
Email
|
|
| Karl Beutner, M.d., Ph.d. | CEO and Co-founder at Dermbiont, Inc. |
View
|
|
| Ravi Pandrapragada | Senior Vice President of Development | Clarksburg, Maryland, United States |
Email
|
Employees by Management Level
Executive
4 profiles
Individual contributor
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 1 | 1 | 0 |
| IT | 1 | 1 | 0 |
DermBiont, Inc. Tech Stack
Data / AI
2 profiles
Compare Similar Companies to DermBiont, Inc.
AbbVie
Pharmaceutical Manufacturing
Amgen
Biotechnology Research
LEO Pharma
Pharmaceutical Manufacturing
Alto Pharmacy
Hospitals And Health Care
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Biotechnology Research
Roivant
Biotechnology
VYNE Therapeutics Inc.
Biotechnology Research
CymaBay Therapeutics
Pharmaceutical Manufacturing
Olive Tree Capital
Investment Management
BrickBuilt Therapeutics Inc. (acquired by Dermbiont, Inc.)
Biotechnology Research